Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Cohort (CHRT) by Roland Head in The Motley Fool
- Buy British American Tobacco (BATS) by G A Chester in The Motley Fool
- Buy Tracsis (TRCS) by Roland Head in The Motley Fool
- Sell UK Oil & Gas (UKOG) by Tom Winnifrith in ShareProphets
- Buy Smurfit Kappa Group (SKG) by Royston Wild in The Motley Fool
- Avoid BHP Billiton (BLT) by Kevin Godbold in The Motley Fool
- Buy Barratt Developments (BDEV) by Peter Stephens in The Motley Fool
- Buy BP (BP.) by Roland Head in The Motley Fool
- Buy Wood Group (John) (WG.) by Roland Head in The Motley Fool
- Buy Admiral Group (ADM) by Royston Wild in The Motley Fool
- Buy Ariana Resources (AAU) by Hot Stock Rockets in Five Free Share Tips
- Buy San Leon Energy (SLE) by UBS
- Buy Tekmar Group (TGP) by Berenberg
- Buy Ceres Power Holdings (CWR) by Berenberg
- Buy G4S (GFS) by UBS
- Hold NWF Group (NWF) by Shore Capital
- Risky Buy Cairn Energy (CNE) by Canaccord Genuity
- Buy EP Global Opportunities Trust (EPG) by Rupert Hargreaves in The Motley Fool
- Sell LiDCO Group (LID) by Steve Moore in ShareProphets
- Sell Woodford Patient Capital Trust (WPCT) by Rupert Hargreaves in The Motley Fool
AstraZeneca (AZN)
Pharma and Biotech Sector
-
Latest quote
5,956.00p (mid)
-
Current Change (%)
-0.32%
-
Price
Bid: 5,960.00p
Offer: 5,961.00p
-
Today
High: 6,008.00p
Low: 5,934.00p
-
This year
High: 6,107.00p
Low: 4,418.00p
-
Information
Volume: 647,412
Market Cap: £75466.26M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
| Title | Release date |
|---|---|
| AZ's Tagrisso approved in Japan for 1st-line NSCLC | 07:00 - August 21, 2018 |
| AstraZeneca prices a $3bn bond issue | 07:00 - August 15, 2018 |
| EMA grants OD for selumetinib in NF1 | 07:00 - August 3, 2018 |
| Total Voting Rights | 15:00 - August 1, 2018 |
| CHMP recommends Imfinzi for Stage III nsclc | 14:00 - July 27, 2018 |
| Atacand to be divested to Cheplapharm in Europe | 07:00 - July 24, 2018 |
| Holding(s) in Company | 16:11 - July 18, 2018 |
| Holding(s) in Company | 12:00 - July 18, 2018 |
| Total Voting Rights | 15:00 - July 2, 2018 |
| Lynparza approved in Japan for BRCAm breast cancer | 07:00 - July 2, 2018 |
| Imfinzi approved in Japan for Stage III nsclc | 07:00 - July 2, 2018 |
| Bydureon receives positive CHMP opinion for BCise | 15:00 - June 29, 2018 |
| AZ and Luye Pharma complete agreement for Seroquel | 13:30 - June 28, 2018 |
| Lynparza: significant PFS 1st-line ovarian cancer | 07:00 - June 27, 2018 |
| Board Committee Changes | 07:00 - June 26, 2018 |
NOTE: This is based on 168 open tips for this company
